Search

$269 Million Construction Loan for South Florida Mixed-Use Project Is Among Largest of Its Kind “This transaction underlines the strength of Peter [Baytarian]’s vision and the importance of the Nautilus 220 project to the area,” said Anthony Kang, a partner with Saul Ewing.

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...